Table 1.

Association of replicated CASP GWAS signals with PsA.

						PsC vs. control (3523 cases, 5942 controls)				PsA vs. control (1755 cases, 5942 controls)				PsA vs. PsC (1755 cases, 3523 controls)
Marker	Chr	Position (bld 36.1)	Nearby Notable Gene	Alleles (risk/ nonrisk)	·	freq cases	freq controls	meta OR	meta allelic p-value	freq cases	freq controls	meta OR	meta allelic p-value	freq cases	freq controls	meta OR	meta allelic p-value
rs12191877	6	3.1E+O7	HLA-C	T/C		0.316	0.139	2.87	2.98E-178	0.260	0.139	2.34	6.26E-62	0.260	0.316	0.87	6.14E-03
rs2082412	S	I.6E+O8	1L12B	G/A		0.846	0.797	1.42	4.57E-18	0.861	0.797	1.63	3.90E-16	0.861	0.846	1.19	9.51E-03
rs17728338	5	1.5E+O8	TNIP1	A/G		0.083	0.054	1.56	1.40E-13	0.100	0.054	1.78	2.32E-14	0.100	0.083	1.15	7.43E-02
rs20541	5	1.3E+O8	IL13	G/A		0.821	0.787	1.24	3.77E-08	0.833	0.787	1.34	1.35E-07	0.833	0.821	1.10	1.13E-01
rs610604	6	1.4E+08	TNFAIP3	G/T		0.364	0.318	1.23	3.O7E-1O	0.362	0.318	1.18	2.94E-04	0.362	0.364	0.98	6.70E-01
rs2O668O7	12	5.5E+O7	IL23A	C/G		0.949	0.932	1.33	1.9OE-O5	O.955	0.932	1.55	9.49E-06	0.955	0.949	1.15	2.25E-01
rs2201841	1	6.7E+07	IL23R	G/A		0.340	0.295	1.23	1.75E-1O	0.318	0.295	1.07	1.42E-01	0.318	0.340	0.89	1.50E-02